Western Pacific Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$46.2K Hold
50
0.05% 122
2025
Q4
$54K Hold
50
0.05% 112
2025
Q3
$38.3K Hold
50
0.04% 135
2025
Q2
$39.2K Hold
50
0.04% 140
2025
Q1
$41.5K Hold
50
0.04% 134
2024
Q4
$38.8K Hold
50
0.03% 148
2024
Q3
$44.5K Hold
50
0.03% 172
2024
Q2
$45.4K Hold
50
0.03% 151
2024
Q1
$39K Hold
50
0.03% 157
2023
Q4
$29.1K Hold
50
0.02% 166
2023
Q3
$26.9K Hold
50
0.02% 171
2023
Q2
$23.4K Hold
50
0.02% 178
2023
Q1
$17.2K Hold
50
0.01% 188
2022
Q4
$18.3K Hold
50
0.02% 179
2022
Q3
$16K Hold
50
0.02% 182
2022
Q2
$16K Hold
50
0.02% 132
2022
Q1
$14K Buy
+50
New +$12.9K 0.01% 158

Other funds holding LLY

Western Pacific Wealth Management's LLY Position: Q1 2026 in Review

Western Pacific Wealth Management held its Eli Lilly (LLY) position steady in Q1 2026 at 50 shares worth $46.2K. The position accounts for 0.05% of the portfolio, ranked #122.

Western Pacific Wealth Management first reported a position in LLY in Q1 2022 and has held it in 17 quarters since. The position peaked at $54K in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Western Pacific Wealth Management held 50 shares of Eli Lilly worth $46.2K as of Q1 2026.
  • Western Pacific Wealth Management left its Eli Lilly share count unchanged in Q1 2026.
  • Eli Lilly made up 0.05% of Western Pacific Wealth Management's portfolio in Q1 2026, its #122 holding.
  • Western Pacific Wealth Management first reported a position in Eli Lilly in Q1 2022 and has held it in 17 quarters since.
  • Western Pacific Wealth Management's Eli Lilly position peaked at $54K in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Western Pacific Wealth Management's 13F filing for Q1 2026, filed 17 Apr 2026.